KORU Medical Systems, Inc.
KRMD
$4.32
$0.051.17%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 23.27% | 27.17% | 20.93% | 17.53% | 23.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 23.27% | 27.17% | 20.93% | 17.53% | 23.00% |
| Cost of Revenue | 24.49% | 38.20% | 26.05% | 15.97% | 14.74% |
| Gross Profit | 22.55% | 20.80% | 18.18% | 18.48% | 28.44% |
| SG&A Expenses | 3.67% | 16.91% | 1.21% | 11.23% | 16.24% |
| Depreciation & Amortization | -15.27% | -10.23% | -3.85% | -6.05% | -7.36% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.73% | 14.03% | 9.20% | 7.10% | 11.13% |
| Operating Income | 65.58% | 49.06% | 73.77% | 36.52% | 27.67% |
| Income Before Tax | 69.06% | 50.78% | 80.83% | 39.76% | 22.89% |
| Income Tax Expenses | 62.07% | -- | -- | -- | -99.95% |
| Earnings from Continuing Operations | 68.81% | 50.78% | 79.07% | 39.76% | 79.09% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 68.81% | 50.78% | 79.07% | 39.76% | 79.09% |
| EBIT | 65.58% | 49.06% | 73.77% | 36.52% | 27.67% |
| EBITDA | 67.48% | 55.05% | 89.41% | 40.60% | 24.15% |
| EPS Basic | 69.21% | 51.30% | 79.17% | 40.09% | 79.14% |
| Normalized Basic EPS | 69.34% | 51.16% | 80.74% | 40.00% | 23.47% |
| EPS Diluted | 60.70% | 51.30% | 79.17% | 40.09% | 79.14% |
| Normalized Diluted EPS | 69.34% | 51.16% | 80.74% | 40.00% | 23.47% |
| Average Basic Shares Outstanding | 1.07% | 0.85% | 0.83% | 0.59% | 0.36% |
| Average Diluted Shares Outstanding | 1.07% | 0.85% | 0.83% | 0.59% | 0.36% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |